Cargando…
Clinical, pathophysiologic, and genomic analysis of the outcomes of primary head and neck malignancy after pulmonary metastasectomy
The median overall survival (OS) of some head and neck malignancies, such as head and neck squamous cell carcinoma (HNSCC), with metastatic lesions was only 12 months. Whether aggressive pulmonary metastasectomy (PM) improves survival is controversial. Patients with primary head and neck malignancy...
Autores principales: | Lu, Hsueh-Ju, Hsieh, Chih-Cheng, Yeh, Chi-Chun, Yeh, Yi-Chen, Wu, Chun-Chi, Wang, Feng-Sheng, Lai, Jin-Mei, Yang, Muh-Hwa, Wang, Cheng-Hsu, Huang, Chi-Ying F., Chang, Peter Mu-Hsin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733860/ https://www.ncbi.nlm.nih.gov/pubmed/31501464 http://dx.doi.org/10.1038/s41598-019-49212-y |
Ejemplares similares
-
TRPM7 via calcineurin/NFAT pathway mediates metastasis and chemotherapeutic resistance in head and neck squamous cell carcinoma
por: Chen, Tsung-Ming, et al.
Publicado: (2022) -
Ferroptosis Signature Shapes the Immune Profiles to Enhance the Response to Immune Checkpoint Inhibitors in Head and Neck Cancer
por: Chung, Chih‐Hung, et al.
Publicado: (2023) -
Cisplatin/Tegafur/Uracil/Irinotecan Triple Combination Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: A Phase I/II Clinical Study
por: Chen, San-Chi, et al.
Publicado: (2016) -
Modified Weekly Cisplatin-Based Chemotherapy Is Acceptable in Postoperative Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Cancer
por: Lu, Hsueh-Ju, et al.
Publicado: (2015) -
KDM5D Histone Demethylase Identifies Platinum-Tolerant Head and Neck Cancer Cells Vulnerable to Mitotic Catastrophe
por: Chen, Tsung-Ming, et al.
Publicado: (2023)